跳至主要内容
临床试验/IRCT20201116049406N1
IRCT20201116049406N1已完成2 期

Comparing the effectiveness of Aripiprazole with other second-generation antipsychotics on smoking dependency in manic patients admitted

Arak University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Conscious consent to participate in the study
  • Smokers over 18 years of age with bipolar I psychiatric disorder in phase mania (based on DSM-V)

排除标准

  • All patients who do not want to continue the study and do not consent to participate in the study.
  • Patients who have been taking antipsychotic medications for the past 30 days.
  • Patients who have been treated with ECT for the past 6 months.
  • Pregnancy or lactation, Alcohol dependence, Mental disorder other than bipolar disorder, High risk of suicide, Use of non-loading dose stabilizing drugs other than sodium valproate, Liver disorders, History of polycystic ovary and thrombocytopenia

研究者

相似试验

effectiveness of Aripiprazole on smoking dependency... | 临床试验